Is IRIDEX Corporation (IRIX) overvalued? · rev $12.6M
IRIDEX Corporation (IRIX) is a medical devices company listed on US.
This page asks whether IRIDEX Corporation (IRIX) looks expensive on cached numbers — not a short thesis.
Latest reported IRIX revenue for 2026-07-04 was $12.6M. Net income was -$1.3M. Revenue was up 6.5% from 2026-04-04 to 2026-07-04. IRIX currently screens at market cap $19.0M.
IRIX currently screens at market cap $19.0M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next IRIX 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the IRIX stock page for the full model, not this heading.
Not investment advice.